✦ LIBER ✦

Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor

✍ Scribed by Fergus McTaggart; Linda Buckett; Robert Davidson; Geoffry Holdgate; Alex McCormick; Dennis Schneck; Graham Smith; Michael Warwick

Book ID: 113974700
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 225 KB
Volume: 87
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(01)01454-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of 3-hydroxy-3-met

Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

✍ Mohammed H. Moghadasian 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 664 KB

Pharmacokinetics and disposition of rosu

Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat

✍ Nezasa, K.; Takao, A.; Kimura, K.; Takaichi, M.; Inazawa, K.; Koike, M. 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 412 KB

Biological and pharmacological activity

Biological and pharmacological activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase

✍ Endo, Akira 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Tachyphylaxis in 3-hydroxy-3-methylgluta

Tachyphylaxis in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

✍ Peter H. Jones 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Antileukemic properties of 3-hydroxy-3-m

Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

✍ van Besien, Herman; Sassano, Antonella; Altman, Jessica K.; Platanias, Leonidas 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 448 KB

Regulation of 3-hydroxy-3-methylglutaryl

Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase

✍ Gene C. Ness 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 634 KB

Within the last few years considerable evidence has accumulated which indicates that changes in HMG-CoA reductase are due primarily, if not solely, to changes in enzyme quantity. These include the changes caused by insulin, glucagon, cholesterol, mevalonolactone, cholestyramine, compactin, cyclic mo